NIH R01 · 2024
ABSTRACT With the support of PAS-20-160 “Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK,” we will perform a feasibility study to test our overall hypothesis that TRE presents a viable alternative to caloric restriction for improving glycemic measures and reducing weight in overweight/obese patients [BMI:25-35 kg/m2] with metformin-only treated Type 2 diabetes (T2DM). The rationale for this study arises from the observation that intentional caloric restriction plays an integral part in glycemic management in patients with newly diagnosed/early-stage T2DM. Yet intentional caloric restriction is difficult to sustain due to multiple barriers, including challenges…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.